MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer. Kitajima S, Tani T, Springer BF, Campisi M, et al. Cancer Cell 2022 Sep 18. pii: S1535-6108(22)00379.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kitajima S, Tani T, Springer BF, Campisi M, et al. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer. Cancer Cell 2022 Sep 18. pii: S1535-6108(22)00379.
PMID: 36150391